Imperial College London
Portrait Picture

Professor Christoph Lees, MD FRCOG

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Professor of Obstetrics
 
 
 
//

Contact

 

+44 (0)20 7594 5770c.lees

 
 
//

Assistant

 

Ms Hazel Blackman +44 (0)20 7594 2104

 
//

Location

 

Queen Charlottes and Chelsea HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fantasia:2022:10.1111/aogs.14466,
author = {Fantasia, I and Zamagni, G and Lees, C and Mylrea-Foley, B and Monasta, L and Mullins, E and Prefumo, F and Stampalija, T},
doi = {10.1111/aogs.14466},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
pages = {1431--1439},
title = {Current practice in the diagnosis and management of fetal growth restriction: An international survey},
url = {http://dx.doi.org/10.1111/aogs.14466},
volume = {101},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - IntroductionThe aim of this survey was to evaluate the current practice in respect of diagnosis and management of fetal growth restriction among obstetricians in different countries.Material and methodsAn e-questionnaire was sent via REDCap with “click thru” links in emails and newsletters to obstetric practitioners in different countries and settings with different levels of expertise. Clinical scenarios in early and late fetal growth restriction were given, followed by structured questions/response pairings.ResultsA total of 275 participants replied to the survey with 87% of responses complete. Participants were obstetrician/gynecologists (54%; 148/275) and fetal medicine specialists (43%; 117/275), and the majority practiced in a tertiary teaching hospital (56%; 153/275). Delphi consensus criteria for fetal growth restriction diagnosis were used by 81% of participants (223/275) and 82% (225/274) included a drop in fetal growth velocity in their diagnostic criteria for late fetal growth restriction. For early fetal growth restriction, TRUFFLE criteria were used for fetal monitoring and delivery timing by 81% (223/275). For late fetal growth restriction, indices of cerebral blood flow redistribution were used by 99% (250/252), most commonly cerebroplacental ratio (54%, 134/250). Delivery timing was informed by cerebral blood flow redistribution in 72% (176/244), used from ≥32 weeks of gestation. Maternal biomarkers and hemodynamics, as additional tools in the context of early-onset fetal growth restriction (≤32 weeks of gestation), were used by 22% (51/232) and 46% (106/230), respectively.ConclusionsThe diagnosis and management of fetal growth restriction are fairly homogeneous among different countries and levels of practice, particularly for early fetal growth restriction. Indices of cerebral flow distribution are widely used in the diagnosis and management of late fetal growth restriction, whereas maternal biomarkers and hemodynam
AU  - Fantasia,I
AU  - Zamagni,G
AU  - Lees,C
AU  - Mylrea-Foley,B
AU  - Monasta,L
AU  - Mullins,E
AU  - Prefumo,F
AU  - Stampalija,T
DO  - 10.1111/aogs.14466
EP  - 1439
PY  - 2022///
SN  - 0001-6349
SP  - 1431
TI  - Current practice in the diagnosis and management of fetal growth restriction: An international survey
T2  - Acta Obstetricia et Gynecologica Scandinavica
UR  - http://dx.doi.org/10.1111/aogs.14466
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000865473800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.14466
UR  - http://hdl.handle.net/10044/1/100255
VL  - 101
ER  -
Download